Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01315834
Other study ID # MMC10psycho-cardioCTIL
Secondary ID
Status Recruiting
Phase N/A
First received January 11, 2011
Last updated March 16, 2012
Start date April 2011
Est. completion date December 2014

Study information

Verified date March 2012
Source Meir Medical Center
Contact Morris Mosseri, Professor
Phone 972-9-7472587
Email Morris.Mosseri@clalit.org.il
Is FDA regulated No
Health authority Israel: Clalit Health Services
Study type Observational

Clinical Trial Summary

The main purpose of this study is to examine the contribution of personality traits to marital satisfaction and well -being among couples coping with Coronary Heart Disease (CHD) and couples from the general population, and to health promoting behaviors and physical recovery among the ill partners.


Description:

Heart disease is the world's leading cause of death in most industrial countries and it requires drastic changes in the lifestyle of the patient. Research on social support and coping with stress has repeatedly shown that being in a supportive spousal relationship has a significant effect on the recovery from a heart disease through alterations in mood, as well as through health habits. However, there are interpersonal differences in the abilities to receive and to provide support. Most of the literature to date has focused either on the experiences of the support recipient or on the support provider; much less research has taken both partners' characteristics into consideration (Revenson & DeLongis, 2011).

The current research aims to broaden the understanding of spousal support among couples coping with a life threatening illness- Coronary Heart Disease (CHD) versus general population of couples. Two studies were designed. Study 1(control group) will focus on general population of couples and its goal is examine the contribution of personality traits of the couples to their marital satisfaction and well-being. Study 2 (target group) will focus on couples coping with a first acute coronary heart disease and its goal is to examine the contribution of personality traits of the couples to their marital satisfaction and well-being, and to health promoting behaviors (smoking cessation, medication adherence) and physical recovery (change in body mass index, change in cholesterol levels) of the ill partners.

The proposed research is a prospective, longitudinal study. The control group will be 100 couples who are not coping with a life threatening illness. The couples will complete self report questionnaires. The target group will be 127 male patients and their partners. The couples will be recruited during the patients' first hospitalization for ACS. The participants will complete questionnaires during the hospitalization and again six months later. Relevant data will be obtained from their medical files.

This study's findings could inform clinicians whose goal is to foster better patient-spouse dynamics in the context of major medical stressors. Helping couples master the challenge of providing and receiving support in such trying times may contribute to enhanced levels of adherence among patients which, in turn, would lead to improved health and saved lives.


Recruitment information / eligibility

Status Recruiting
Enrollment 130
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Jewish men with a Clinical diagnosis of first Acute Coronary Syndrome (ACS: myocardial infarction (MI) or unstable angina (UA))

- Partners also agree to participate in the study

Exclusion Criteria:

- a history of a previous cardiac event

- a diagnosis other than ACS

- co-morbid conditions (such as a severe psychiatric illness, end state renal disease or severe cancer)

- absence of a spouse

- inability to be interviewed in Hebrew

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Locations

Country Name City State
Israel Department of Cardiology, Meir Medical Center Kefar Saba

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patients' medication adherence Medication adherence: the number of prescriptions filled as a function of the frequency of the medication. will be obtained from the central database of the patients' HMO. Six months after hospitalization No
Primary Change in blood level Cholesterol Change in blood level Cholesterol:Patients' blood level Cholesterol will be taken at baseline from their medical files and at the follow-up patients will be invited again for blood tests. six mounths No
Primary Change in body mass index Change in body mass index:Patients' BMI will be measured at baseline and Patients will be asked to weigh in again at the six-month follow-up six-month No
Primary Smoking cessation Smoking cessation:self-report measures of the patients'smoking cessation at follow-up. six months No
Primary Change in blood level Cholesterol Change in blood level Cholesterol:Patients' blood level Cholesterol will be taken at baseline and at the follow-up from their medical files. six mounths No
Secondary Patients' and spouses' depression and anxiety symptoms Depression and anxiety- depressive and anxiety symptoms will be measured using the Brief Symptom Inventory [BSI;( Derogatis & Melisaratos, 1983)]. Each participant will be asked to rate the degree to which he has suffered from each symptom during the previous month on a scale ranging from 0 (not at all) to 4 (very much). Case group- the instruments will be administered twice: at baseline and at the six- month follow-up Control group- the instruments will be administered at a one point of time No
Secondary Patients' and spouses' marital satisfaction Marital satisfaction - marital satisfaction will be measured using the EMS-ENRICH Marital Satisfaction Scale (Lavee, 1995(. Case group- the instruments will be administered twice: at baseline and at the six- month follow-up Control group- the instruments will be administered at a one point of time No
See also
  Status Clinical Trial Phase
Withdrawn NCT01631409 - Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy N/A
Completed NCT04610892 - Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction Phase 2
Recruiting NCT05834673 - VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) Phase 4
Completed NCT00685776 - Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019) Phase 3
Active, not recruiting NCT03872401 - Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Phase 3
Completed NCT03427489 - A Biorepository for Coronary Heart Disease in Qatar
Active, not recruiting NCT01864031 - The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study N/A
Not yet recruiting NCT05178602 - The Effect of TaiChi on Ischemic Burden of Patients With Coronary Heart Disease Complicated With Renal Insufficiency N/A
Not yet recruiting NCT06216847 - Clinical Outcomes of Patients With Coronary Artery Disease
Recruiting NCT06170541 - CORE-COMPARE Pilot Study N/A